Guided Therapeutics, Inc. (GTHP)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 632 Thousand USD | 15.33% |
| 2022 | 548 Thousand USD | -4.03% |
| 2021 | 571 Thousand USD | -5.62% |
| 2020 | 605 Thousand USD | 1160.42% |
| 2019 | 48 Thousand USD | -57.89% |
| 2018 | 114 Thousand USD | -56.98% |
| 2017 | 265 Thousand USD | -65.72% |
| 2016 | 773 Thousand USD | -30.92% |
| 2015 | 1.11 Million USD | -5.17% |
| 2014 | 1.18 Million USD | -1.09% |
| 2013 | 1.19 Million USD | 127.67% |
| 2012 | 524 Thousand USD | 0.77% |
| 2011 | 520 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 184 Thousand USD | -34.75% |
| 2005 | 282 Thousand USD | -22.31% |
| 2004 | 363 Thousand USD | 52.52% |
| 2003 | 238 Thousand USD | -62.99% |
| 2002 | 643 Thousand USD | 47.14% |
| 2001 | 437 Thousand USD | -9.15% |
| 2000 | 481 Thousand USD | -3.8% |
| 1999 | 500 Thousand USD | 25.0% |
| 1998 | 400 Thousand USD | 81.82% |
| 1997 | 220 Thousand USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 632 Thousand USD | 0.0% |
| 2024 Q2 | 632 Thousand USD | 0.0% |
| 2023 FY | 632 Thousand USD | 15.33% |
| 2023 Q1 | 585 Thousand USD | 6.75% |
| 2023 Q2 | 573 Thousand USD | -2.05% |
| 2023 Q3 | 648 Thousand USD | 13.09% |
| 2023 Q4 | 632 Thousand USD | -2.47% |
| 2022 Q1 | 570 Thousand USD | -0.18% |
| 2022 FY | 548 Thousand USD | -4.03% |
| 2022 Q2 | 569 Thousand USD | -0.18% |
| 2022 Q3 | 596 Thousand USD | 4.75% |
| 2022 Q4 | 548 Thousand USD | -8.05% |
| 2021 Q2 | 631 Thousand USD | 4.13% |
| 2021 Q1 | 606 Thousand USD | 0.17% |
| 2021 Q3 | 590 Thousand USD | -6.5% |
| 2021 FY | 571 Thousand USD | -5.62% |
| 2021 Q4 | 571 Thousand USD | -3.22% |
| 2020 FY | 605 Thousand USD | 1160.42% |
| 2020 Q1 | 57 Thousand USD | 18.75% |
| 2020 Q2 | 51 Thousand USD | -10.53% |
| 2020 Q3 | 53 Thousand USD | 3.92% |
| 2020 Q4 | 605 Thousand USD | 1041.51% |
| 2019 Q1 | 112 Thousand USD | -1.75% |
| 2019 Q4 | 48 Thousand USD | 0.0% |
| 2019 Q3 | 48 Thousand USD | 0.0% |
| 2019 Q2 | 48 Thousand USD | -57.14% |
| 2019 FY | 48 Thousand USD | -57.89% |
| 2018 FY | 114 Thousand USD | -56.98% |
| 2018 Q3 | 265 Thousand USD | -5.36% |
| 2018 Q1 | 295 Thousand USD | 11.32% |
| 2018 Q2 | 280 Thousand USD | -5.08% |
| 2018 Q4 | 114 Thousand USD | -56.98% |
| 2017 Q4 | 265 Thousand USD | -54.07% |
| 2017 FY | 265 Thousand USD | -65.72% |
| 2017 Q2 | 756 Thousand USD | -9.57% |
| 2017 Q3 | 577 Thousand USD | -23.68% |
| 2017 Q1 | 836 Thousand USD | 8.15% |
| 2016 Q4 | 773 Thousand USD | -33.99% |
| 2016 Q2 | 1.23 Million USD | -1.2% |
| 2016 Q3 | 1.17 Million USD | -5.41% |
| 2016 FY | 773 Thousand USD | -30.92% |
| 2016 Q1 | 1.25 Million USD | 11.97% |
| 2015 Q1 | 1.14 Million USD | -2.63% |
| 2015 Q2 | 985 Thousand USD | -14.27% |
| 2015 Q3 | 912 Thousand USD | -7.41% |
| 2015 FY | 1.11 Million USD | -5.17% |
| 2015 Q4 | 1.11 Million USD | 22.7% |
| 2014 Q4 | 1.18 Million USD | -1.99% |
| 2014 FY | 1.18 Million USD | -1.09% |
| 2014 Q2 | 1.11 Million USD | -10.77% |
| 2014 Q1 | 1.25 Million USD | 5.11% |
| 2014 Q3 | 1.2 Million USD | 7.6% |
| 2013 Q2 | 607 Thousand USD | 38.27% |
| 2013 FY | 1.19 Million USD | 127.67% |
| 2013 Q3 | 810 Thousand USD | 33.44% |
| 2013 Q1 | 439 Thousand USD | -16.22% |
| 2013 Q4 | 1.19 Million USD | 47.28% |
| 2012 Q1 | 608 Thousand USD | 16.92% |
| 2012 Q2 | 459 Thousand USD | -24.51% |
| 2012 Q4 | 524 Thousand USD | 13.67% |
| 2012 FY | 524 Thousand USD | 0.77% |
| 2012 Q3 | 461 Thousand USD | 0.44% |
| 2011 FY | 520 Thousand USD | 0.0% |
| 2011 Q4 | 520 Thousand USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 100.0% |
| 2008 Q1 | -3000.00 USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2006 Q3 | 258 Thousand USD | -39.01% |
| 2006 FY | 184 Thousand USD | -34.75% |
| 2006 Q1 | 327 Thousand USD | 15.96% |
| 2006 Q2 | 423 Thousand USD | 29.36% |
| 2006 Q4 | 184 Thousand USD | -28.68% |
| 2005 FY | 282 Thousand USD | -22.31% |
| 2005 Q4 | 282 Thousand USD | -5.05% |
| 2005 Q3 | 297 Thousand USD | -25.38% |
| 2005 Q2 | 398 Thousand USD | 3.92% |
| 2005 Q1 | 383 Thousand USD | 5.51% |
| 2004 Q2 | 306 Thousand USD | 0.99% |
| 2004 Q3 | 233 Thousand USD | -23.86% |
| 2004 Q4 | 363 Thousand USD | 55.79% |
| 2004 Q1 | 303 Thousand USD | 27.31% |
| 2004 FY | 363 Thousand USD | 52.52% |
| 2003 Q3 | 181 Thousand USD | 16.03% |
| 2003 Q1 | 43 Thousand USD | -93.31% |
| 2003 FY | 238 Thousand USD | -62.99% |
| 2003 Q4 | 238 Thousand USD | 31.49% |
| 2003 Q2 | 156 Thousand USD | 262.79% |
| 2002 Q2 | 771 Thousand USD | 59.96% |
| 2002 Q3 | 775 Thousand USD | 0.52% |
| 2002 Q1 | 482 Thousand USD | 10.3% |
| 2002 Q4 | 643 Thousand USD | -17.03% |
| 2002 FY | 643 Thousand USD | 47.14% |
| 2001 Q2 | 581 Thousand USD | 7.0% |
| 2001 FY | 437 Thousand USD | -9.15% |
| 2001 Q4 | 437 Thousand USD | -30.08% |
| 2001 Q3 | 625 Thousand USD | 7.57% |
| 2001 Q1 | 543 Thousand USD | 12.89% |
| 2000 Q1 | 416 Thousand USD | -16.8% |
| 2000 FY | 481 Thousand USD | -3.8% |
| 2000 Q4 | 481 Thousand USD | 9.32% |
| 2000 Q3 | 440 Thousand USD | 20.55% |
| 2000 Q2 | 365 Thousand USD | -12.26% |
| 1999 Q4 | 500 Thousand USD | 0.0% |
| 1999 Q3 | 500 Thousand USD | 25.0% |
| 1999 Q2 | 400 Thousand USD | 0.0% |
| 1999 Q1 | 400 Thousand USD | 0.0% |
| 1999 FY | 500 Thousand USD | 25.0% |
| 1998 FY | 400 Thousand USD | 81.82% |
| 1998 Q1 | 500 Thousand USD | 127.27% |
| 1998 Q2 | 400 Thousand USD | -20.0% |
| 1998 Q3 | 400 Thousand USD | 0.0% |
| 1998 Q4 | 400 Thousand USD | 0.0% |
| 1997 FY | 220 Thousand USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | 220 Thousand USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Avitar, Inc. | 225.15 Thousand USD | -180.694% |
| BioElectronics Corporation | 41.05 Thousand USD | -1439.511% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -81.00 USD | 780346.914% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -2056.629% |
| Polarean Imaging plc | 2.21 Million USD | 71.515% |
| AVITA Medical, Inc. | 3.12 Million USD | 79.753% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.536% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -565.964% |
| QHSLab, Inc. | 25.18 Thousand USD | -2409.829% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.536% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 94.336% |
| Escalon Medical Corp. | 1.61 Million USD | 60.821% |
| Aurora Spine Corporation | 3.54 Million USD | 82.168% |
| BrainsWay Ltd. | 3.71 Million USD | 82.997% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 95.602% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.848% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -1267.166% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -537.437% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -5084.578% |
| Nanomix Corporation | - USD | -Infinity% |
| Theraclion SA | 3.05 Million EUR | 79.311% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -402.868% |
| Positron Corporation | 1.25 Million USD | 49.716% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -822.399% |
| Lombard Medical, Inc. | 6.87 Million USD | 90.81% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.599% |
| Vycor Medical, Inc. | 234.14 Thousand USD | -169.918% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -285.705% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -389.926% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 78.584% |
| VMS Rehab Systems, Inc. | 1.33 USD | -47518696.992% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -638.37% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | -101.653% |
| Urologix, Inc. | 1.39 Million USD | 54.76% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -261.046% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 71.358% |
| SS Innovations International, Inc. | 6.32 Million USD | 90.011% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.974% |
| NIOX Group Plc | 6.11 Million USD | 89.657% |
| Fuse Medical, Inc. | 9.11 Million USD | 93.07% |
| Broncus Holding Corporation | 4.7 Million USD | 86.575% |
| Brain Scientific Inc. | 149.55 Thousand USD | -322.579% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | -107.275% |
| Health Logic Interactive Inc. | -4511.80 USD | 14107.713% |